Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.

Abstract

The results of a double-blind trial on the clinical and functional effects induced by domiodol and S-carboxymethylcysteine (SCMC) on 40 patients with chronic obstructive lung disease are discussed. Although the therapeutic effects of the two drugs showed no statistical differences both substances had a positive effect on all patients. In general domiodol took effect more rapidly, a feature that is often very convenient.

• Authors: L Casali, C Rampulla, A Rossi
• Journal: International journal of clinical pharmacology, therapy, and toxicology (Int J Clin Pharmacol Ther Toxicol) Vol. 20 Issue 11 Pg. 554-7 (Nov 1982) ISSN: 0174-4879 [Print] Germany
• PMID: 6757153 (Publication Type: Clinical Trial, Comparative Study, Journal Article)

Chemical References

• Dioxolanes
• Dioxoles
• Expectorants
• Carbocysteine
• domiodol
• Cysteine

Topics

• Adult
• Aged
• Carbocysteine (therapeutic use)
• Clinical Trials as Topic
• Cysteine (analogs & derivatives)
• Dioxolanes (therapeutic use)
• Dioxoles (therapeutic use)
• Double-Blind Method
• Expectorants (therapeutic use)
• Female
• Humans
• Lung Diseases, Obstructive (drug therapy)
• Male
• Middle Aged
• Random Allocation